Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

200.64 +2.83 (+1.43%)
Streaming Delayed Price Updated: 3:05 PM EDT, Apr 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 369,766
Open 199.37
Bid (Size) 200.63 (80)
Ask (Size) 200.78 (200)
Prev. Close 197.81
Today's Range 198.80 - 203.59
52wk Range 194.61 - 354.88
Shares Outstanding 68,873,869
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
2 High-Flying Stocks to Own for Decades and 1 We Turn Down
Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lo... 
Via StockStory
Topics Supply Chain
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD
From Pomerantz LLP
Via GlobeNewswire

Performance

YTD
-29.1%
-29.1%
1 Month
-10.7%
-10.7%
3 Month
-28.0%
-28.0%
6 Month
-36.2%
-36.2%
1 Year
-21.5%
-21.5%

More News

Read More
News headline image
Insulet (PODD): 3 Reasons We Love This Stock
Via StockStory
News headline image
Eli Lilly Secures Landmark FDA Approval for Oral Weight-Loss Pill, Sending Shares Soaring
Via MarketMinute
Topics Economy
Insulet Corp (NASDAQ:PODD): A Prime GARP Investment with Strong Growth and Reasonable Valuation ↗
Via Chartmill
News headline image
Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026
From Insulet Corporation
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD
From Pomerantz LLP
Via GlobeNewswire
What's going on in today's pre-market session: S&P500 movers ↗
Via Chartmill
News headline image
Winners And Losers Of Q4: Insulet (NASDAQ:PODD) Vs The Rest Of The Patient Monitoring Stocks
Via StockStory
Topics Artificial Intelligence
News headline image
Insulet Appoints Mike Panos as Chief Commercial Officer
From Insulet Corporation
Via Business Wire
News headline image
PODD Investors Have Opportunity to Join Insulet Corporation Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know
Via StockStory
Topics Artificial Intelligence Government Stocks
News headline image
3 S&P 500 Stocks for Long-Term Investors
Via StockStory
Topics Stocks
Stay informed with the top movers within the S&P500 index on Wednesday. ↗
Via Chartmill
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD
From Pomerantz LLP
Via GlobeNewswire
News headline image
Securities Fraud Investigation Into Insulet Corporation (PODD) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
Securities Fraud Investigation Into Insulet Corporation (PODD) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
From Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Insulet Corporation (PODD) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
1 Healthcare Stock with Exciting Potential and 2 We Avoid
Via StockStory
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insulet Corporation - PODD
From Pomerantz LLP
Via GlobeNewswire
News headline image
This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment ↗
Via The Motley Fool
News headline image
This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
EXCLUSIVE: Just 5 Female CEOs In A 50-Stock ETF — C-Suite Execs Explain The Leadership Gap In Corporate America ↗
Via Benzinga
Topics ETFs Stocks
News headline image
Securities Fraud Investigation Into Insulet Corporation (PODD) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
Insulet Corporation (PODD) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire

Frequently Asked Questions

Is Insulet Corporation - Common Stock publicly traded?
Yes, Insulet Corporation - Common Stock is publicly traded.
What exchange does Insulet Corporation - Common Stock trade on?
Insulet Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Insulet Corporation - Common Stock?
The ticker symbol for Insulet Corporation - Common Stock is PODD on the Nasdaq Stock Market
What is the current price of Insulet Corporation - Common Stock?
The current price of Insulet Corporation - Common Stock is 200.64
When was Insulet Corporation - Common Stock last traded?
The last trade of Insulet Corporation - Common Stock was at 04/14/26 03:05 PM ET
What is the market capitalization of Insulet Corporation - Common Stock?
The market capitalization of Insulet Corporation - Common Stock is 13.82B
How many shares of Insulet Corporation - Common Stock are outstanding?
Insulet Corporation - Common Stock has 14B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.